Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc | REGN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 890.68 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 890.68 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 684.805 - 998.325 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 890.68 | USD |
Regeneron Pharmaceuticals (REGN) Options Flow Summary
Regeneron Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 97.76B | 109.76M | - | 13.12B | 3.95B | 36.02 | 24.73 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Regeneron Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical REGN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 913.97 | 920.73 | 876.75 | 899.07 | 429,717 | -23.29 | -2.55% |
| 1 Month | 962.61 | 970.20 | 876.75 | 917.13 | 454,440 | -71.93 | -7.47% |
| 3 Months | 970.84 | 998.325 | 876.75 | 947.09 | 464,192 | -80.16 | -8.26% |
| 6 Months | 794.58 | 998.325 | 769.19 | 897.55 | 517,538 | 96.10 | 12.09% |
| 1 Year | 781.77 | 998.325 | 684.805 | 832.08 | 531,473 | 108.91 | 13.93% |
| 3 Years | 489.84 | 998.325 | 478.40 | 699.40 | 649,263 | 400.84 | 81.83% |
| 5 Years | 351.25 | 998.325 | 271.37 | 583.36 | 771,528 | 539.43 | 153.57% |
Regeneron Pharmaceuticals Description
| Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently. |
